My watch list
my.bionity.com  
Login  
NEWS
Current news

Crescendo Biologics Expands ADC Programmes with Innovate UK Funding Award

Crescendo Biologics Limited announces it is expanding its antibody drug conjugate (ADC) programme with the support of a Biomedical Catalyst Award from the UK’s innovation agency, Innovate UK. This feasibility award will enable the validation and development of Humabody Drug Conjugates (HDCs ... more

Stem Cell Treatment Speeds Up Recovery after Spinal Cord Injury in Monkeys

A new study appearing in STEM CELLS Translational Medicine, designed to test how stem cell injections affect primates with spinal cord injury (SCI), showed the treatments significantly improved the animals’ motor function recovery and promoted faster healing, too. The researchers call their ... more

Dr. Marijn Dekkers: Bayer has outstanding perspectives as a pure Life Science company

The Bayer Group can look back at a year of significant strategic positioning. “2014 wasn’t just a year full of important strategic decisions for us, it was also a very successful year operationally,” said Management Board Chairman Dr. Marijn Dekkers on Wednesday at the Annual Stockholders’ ... more

Are antidepressants more effective than usually assumed?

Many have recently questioned the efficacy of the most common antidepressant medications, the selective serotonin reuptake inhibitors (SSRIs). The conclusion that these drugs are ineffective is however partly based on a misinterpretation of the outcome of the clinical trials once conducted ... more

BIOTECHNICA and LABVOLUTION: Biologization and digitalization are top themes

Two trade shows, one ticket: For the first time, Deutsche Messe is staging BIOTECHNICA (6 to 8 October 2015) in conjunction with the new LABVOLUTION in order to attract an even wider industry audience to Hannover. While BIOTECHNICA is a showcase for mainstream biotechnology and the life sci ... more

Biocartis and Fast-track diagnostics sign strategic collaboration in infectious diseases

Biocartis and Fast-track diagnostics announced that they have entered into a strategic collaboration to develop a range of multiplex infectious disease tests to run on the Biocartis Idylla™ system. Biocartis and Fast-track diagnostics plan to collaborate on a new approach to infectious dise ... more

Can a viral co-infection impair immunity against Plasmodium and turn malaria lethal?

It is known that infections with certain viruses can weaken the immune response to another pathogen. A study published in PLOS Pathogens reports provocative findings in mice that infection with the mouse equivalent of Epstein-Barr virus (EBV) can turn infections with certain parasites that ... more

New insights could result in changes to the therapeutic strategy to combat Alzheimer’s

A typical characteristic of the brain of an Alzheimer sufferer is the presence of insoluble Tau protein aggregates. Scientists at VIB, KU Leuven and Janssen Pharmaceutica have demonstrated that the distribution of these aggregates through the brain is facilitated by synaptic connections bet ... more

Modifying stem cells shows initial promise in battle against muscular dystrophy

A group of University of Florida Health researchers has found a way to reverse the effects of one type of muscular dystrophy by editing the genome of nervous system stem cells. The findings are an early but important step toward the eventual goal of using stem cell therapy to treat myotonic ... more

AbbVie Completes Acquisition of Pharmacyclics

AbbVie announced that it has completed the acquisition of Pharmacyclics, Inc. enhancing AbbVie's scientific and commercial presence in oncology. Pharmacyclics is a company in the hematological oncology market with Imbruvica® (ibrutinib), a first-in-class BTK-inhibitor used to treat hematolo ... more

All news

New test could identify resistant tuberculosis faster

The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infectio ... more

PhoreMost Awarded £1.4M Innovate UK Funding to Develop Lead Oncology Programme

PhoreMost Ltd announced that it has been selected to receive a funding award of £1.4M (approximately $2.14M USD) from the UK’s innovation agency, Innovate UK, to develop its lead oncology programme targeting mutant KRAS cancers.Based on PhoreMost’s proprietary Protein Interference technolog ... more

NetScientific appoints Dr François R. Martelet as Chief Executive Officer

NetScientific announces the appointment of Dr François R. Martelet as Chief Executive Officer and Board Director.Dr Martelet will join the Group on 8 June 2015. Sir Richard Sykes, who has been Executive Chairman prior to this appointment, will revert to his position as Non-Executive Chairma ... more

Sights set on innovation: New approaches to vision with microchips holds out prospects for the blind

To date, chip-based retinal implants have only permitted a rudimentary restoration of vision. However, modifying the electrical signals emitted by the implants could change that. This is the conclusion of the initial published findings of a project sponsored by the Austrian Science Fund FWF ... more

Protein aggregates save cells during aging

Aging is a complex biological process which is accompanied by an increasing number of toxic protein aggregates in the cells. Scientists consider them the cause of various neurodegenerative disorders, such as Alzheimer's, Huntington's and Parkinson's disease. However, their exact role remain ... more

Small signaling molecule gives green light for cell division

Generating offspring is the evolutionary goal of all living organisms. The multiplication of individual cells is coordinated by the cell cycle. For the discovery of how this process is regulated in eukaryotes the Noble Prize was awarded in 2001. The team of Prof. Urs Jenal at the Biozentrum ... more

Themis Bioscience’s Raises up to EUR 10 Million in Series B

Themis Bioscience announced the first closing of EUR 7 Million in a Series B financing of up to EUR 10 Million, led by new investor Wellington Partners. Existing investors Ventech and Omnes Capital (formerly Crédit Agricole Private Equity) also participated in the round. Dr Regina Hodits, G ... more

QIAGEN partners with sequencing provider

QIAGEN N.V. announced that it has expanded its relationship with BG to provide QIAGEN’s Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI’s sequencing services. Under the reseller agreement, BGI customers will receive sequencing data generated from their sam ... more

Decoding DNA's phonebook

New clues about diseases like inflammatory bowel disorder may be found thanks to a new genomic interactions catalogue by a group of researchers in Japan and the United Kingdom. This research is published in Nature Genetics.Biologists have compiled the most comprehensive catalogue of promote ... more

BIOCITECH: Over 20% increase in revenue for the residents in 2014

Biocitech announced the 2014 results achieved by its residents. Biocitech residents submitted encouraging results for 2014, with growth in many areas. The overall revenue for the complex’s residents grew by 21%, from €51.3 million ($55.5 million) in 2013 to €62 million ($67 million) in 2014 ... more

All news on bioanalytics

Stem Cell Treatment Speeds Up Recovery after Spinal Cord Injury in Monkeys

A new study appearing in STEM CELLS Translational Medicine, designed to test how stem cell injections affect primates with spinal cord injury (SCI), showed the treatments significantly improved the animals’ motor function recovery and promoted faster healing, too. The researchers call their ... more

BIOTECHNICA and LABVOLUTION: Biologization and digitalization are top themes

Two trade shows, one ticket: For the first time, Deutsche Messe is staging BIOTECHNICA (6 to 8 October 2015) in conjunction with the new LABVOLUTION in order to attract an even wider industry audience to Hannover. While BIOTECHNICA is a showcase for mainstream biotechnology and the life sci ... more

Modifying stem cells shows initial promise in battle against muscular dystrophy

A group of University of Florida Health researchers has found a way to reverse the effects of one type of muscular dystrophy by editing the genome of nervous system stem cells. The findings are an early but important step toward the eventual goal of using stem cell therapy to treat myotonic ... more

Cristal Therapeutics Announces Formation of Scientific Advisory Board

Cristal Therapeutics announced the appointments of Prof. Dr. Rob Liskamp, Prof. Dr. Twan Lammers, Prof. Dr. Alberto Gabizon, Dr. Maninder Hora and Dr. William Zamboni to its new Scientific Advisory Board. Prof. Dr. Rob Liskamp is professor and chair of Chemical Biology and Medicinal Chemist ... more

New Standards in Biotechnology

A new working group for data processing and integration in biotechnology has been set up by the International Organization for Standardization, ISO. The working group aims to define consistent standards for the formatting, transfer and integration of life science data and models. The workin ... more

VIB and Performa Investimentos establish GlobalYeast to deliver superior industrial yeast strains

VIB and Performa Investimentos, an independent Brazilian private equity and venture capital company,  announced the establishment of GlobalYeast, a new company that will develop and deliver superior industrial yeast strains for bioethanol and the green chemicals industry. The company raised ... more

Bluebee raises €1.75 million to bring supercomputing to genomics

Bluebee announced a pre-equity round of 1.75 million EUR (1.90 million USD) from investment firm Buysse & Partners and existing shareholder Delft University of Technology to bring its cloud-based, accelerated genomics solution to clinicians and labs. Bluebee’s technology, based on hybrid-co ... more

VTU Technology and Biomay Have Signed License Agreement

VTU Technology and Biomay, two Austrian biotech companies, announced, that they have entered into a licensing agreement for the production of recombinant allergens. VTU Technology grants Biomay access to VTU´s Pichia pastoris protein expression technology. Biomay will apply industrial Pichi ... more

UAlberta creates DNA bank to unlock genetic clues about stuttering

Scientists at the University of Alberta's Institute for Stuttering Treatment and Research (ISTAR) want Albertans to give a spit - five millilitres to be precise - to help find the cause and a cure for stuttering.Scientists at the University of Alberta's Institute for Stuttering Treatment an ... more

Novel insights in MET-proto-oncogene might lead to optimizing cancer treatment

The MET-proto-oncogene is involved in the pathogenesis of several tumors and therefore represents an interesting target for future therapies currently tested in dozens of clinical trials. Veronica Finisguerra, Andrea Casazza, Max Mazzone and colleagues from VIB, KU Leuven and UZ Leuven now ... more

All news on biotechnology

Biocartis and Fast-track diagnostics sign strategic collaboration in infectious diseases

Biocartis and Fast-track diagnostics announced that they have entered into a strategic collaboration to develop a range of multiplex infectious disease tests to run on the Biocartis Idylla™ system. Biocartis and Fast-track diagnostics plan to collaborate on a new approach to infectious dise ... more

New test could identify resistant tuberculosis faster

The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infectio ... more

Detecting lung cancer at an early stage

A new diagnostic method, namely spectral histopathology, facilitates marker-free detection of individual subtypes of lung cancers. It was developed by researchers at the PURE consortium at Ruhr-Universität Bochum (RUB). They have successfully applied it in collaboration with clinicians at t ... more

DNA blood test detects lung cancer mutations

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers has reported at the European Lung Cancer Conference (ELCC) in Gen ... more

Aseptika Granted United States Patent for Biomarkers for Respiratory Infection Onset

Aseptika Limited announced that it has been granted a patent in the United States (US) protecting its invention for a test for respiratory infections, designed to be used by patients at home and by clinicians at the bedside of patients in hospitals. This will open up opportunities for the C ... more

Roche strengthens oncology translational research pipeline by acquiring CAPP Medical

Roche announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA (ctDNA) in blood.  CAPP Med ... more

Bio-marker set forms the basis for new blood test to detect colorectal cancer

Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European ... more

Philips enters into collaboration with Janssen to develop new handheld blood test

Royal Philips announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V.. The collaboration aims to develop a new handheld blood test to provide doctors with a novel tool to improve the care of patients with neuropsychiatric disorders.The collabora ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

All news on diagnostics

BIOTECHNICA and LABVOLUTION: Biologization and digitalization are top themes

Two trade shows, one ticket: For the first time, Deutsche Messe is staging BIOTECHNICA (6 to 8 October 2015) in conjunction with the new LABVOLUTION in order to attract an even wider industry audience to Hannover. While BIOTECHNICA is a showcase for mainstream biotechnology and the life sci ... more

Danaher To Acquire Pall Corporation

Danaher Corporation announced that it has entered into a definitive merger agreement with Pall Corporation pursuant to which Danaher will acquire all of the outstanding shares of Pall for $127.20 per share in cash, or a total enterprise value of approximately $13.8 billion, including assume ... more

SYGNIS signs non-exclusive distribution agreement with Cambridge Bioscience Ltd. for UK and Ireland

SYGNIS AG announced a distribution agreement with Cambridge Bioscience for the commercialization of SYGNIS’ proprietary product portfolio in the UK and Ireland.Under the terms of the agreement, Cambridge Bioscience will promote, market, sell and support TruePrime™ products for primer-free W ... more

Sartorius Starts Off Fiscal 2015 with a Strong First Quarter

Sartorius started off fiscal 2015 with substantial double-digit gains in order intake, sales revenue and earnings. Group order intake rose 13.1%, excluding currency effects; this reported figure surged 22.7%. Sales climbed 17.2% in constant currencies; the reported figure, 27.0%. Operating ... more

Genevac Consolidate Evaporator & Freeze Dryer Operations In Germany

Genevac has announced, as of 1st April 2015, that LMS Consult GmbH (LMS) has been appointed as the exclusive German distributor for its market leading evaporator systems plus the freeze dryer range of its parent company - SP Scientific.For over 30 years - LMS Consulthave successfully sold a ... more

Ximbio Expands Team

Ximbio announced the expansion of its team, with two new appointments. Dr Hugh Spotswood has joined as Senior Business Manager, and Emily Haggerty as a Scientific Portfolio Associate. Hugh’s role as part of Ximbio is to head up the business development function to maximise the revenue creat ... more

INTEGRA Biosciences Opens German Subsidiary

Following on from the successful launch of subsidiaries in France, the UK and the USA - INTEGRA Biosciences has announced the opening in January 2015 of a new organisation based in Konstanz, Germany.Leveraging an existing knowledgeable local sales and service team – INTEGRA Biosciences Deut ... more

TÜV SÜD explains process maturity according to the new ISO 9001

The final version of the revised standard for quality management systems is scheduled for release by the International Organisation for Standardisation (ISO) in autumn 2015. Many organisations have already started to address the expected changes, which are aimed at strengthening the benefit ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

Sartorius Reviews Fiscal 2014 Results

Sartorius closed fiscal 2014 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Germany, CEO Dr. Joachim Kreuzburg stated that the Group had even slightly exceeded its financial targets and reached important milestones: "Our largest division, ... more

All news on lab technology

Crescendo Biologics Expands ADC Programmes with Innovate UK Funding Award

Crescendo Biologics Limited announces it is expanding its antibody drug conjugate (ADC) programme with the support of a Biomedical Catalyst Award from the UK’s innovation agency, Innovate UK. This feasibility award will enable the validation and development of Humabody Drug Conjugates (HDCs ... more

Dr. Marijn Dekkers: Bayer has outstanding perspectives as a pure Life Science company

The Bayer Group can look back at a year of significant strategic positioning. “2014 wasn’t just a year full of important strategic decisions for us, it was also a very successful year operationally,” said Management Board Chairman Dr. Marijn Dekkers on Wednesday at the Annual Stockholders’ ... more

Are antidepressants more effective than usually assumed?

Many have recently questioned the efficacy of the most common antidepressant medications, the selective serotonin reuptake inhibitors (SSRIs). The conclusion that these drugs are ineffective is however partly based on a misinterpretation of the outcome of the clinical trials once conducted ... more

New insights could result in changes to the therapeutic strategy to combat Alzheimer’s

A typical characteristic of the brain of an Alzheimer sufferer is the presence of insoluble Tau protein aggregates. Scientists at VIB, KU Leuven and Janssen Pharmaceutica have demonstrated that the distribution of these aggregates through the brain is facilitated by synaptic connections bet ... more

AbbVie Completes Acquisition of Pharmacyclics

AbbVie announced that it has completed the acquisition of Pharmacyclics, Inc. enhancing AbbVie's scientific and commercial presence in oncology. Pharmacyclics is a company in the hematological oncology market with Imbruvica® (ibrutinib), a first-in-class BTK-inhibitor used to treat hematolo ... more

Sanofi Appoints Suresh Kumar to the Executive Committee and Executive Vice President, External Affairs

Sanofi announced the appointment of Suresh Kumar as a new member of the Executive Committee, effective June 1, 2015. Mr. Kumar joins Sanofi from Oliver Wyman and will take the position of Executive Vice President, External Affairs. In this newly created role, Mr. Kumar will be responsible f ... more

First medicine for rare blood cancer

The European Medicines Agency (EMA) has recommended extending the use of Imbruvica (ibrutinib) to include the treatment of patients with Waldenstrӧm’s macroglobulinaemia, a rare blood cell cancer. Imbruvica is the first medicine that is recommended for this disease.The medicine is indicated ... more

arGEN-X and LEO Pharma Enter into Alliance to Develop Antibody-based Treatments for Skin Conditions

arGEN-X N.V. and LEO Pharma A/S announced an alliance in which they will collaborate to develop  antibody-based solutions for the treatment of chronic inflammation underlying many skin conditions. Under the terms of the agreement, LEO Pharma receives exclusive access to an existing arGEN-X ... more

KCR Accomplishes ISO 9001:2008 Certification for All Company Services

KCR, a Contract Research Organization (CRO), has recently validated the quality and accuracy of its operations receiving ISO 9001:2008 Certification for all its services. The company achieved its first ISO 9001:2008 certification in February 2007, and was recertified in 2010 and 2013. This ... more

Isarna Announces Orphan Drug Designation in the European Union for ISTH0036 to Treat Advanced-Stage Glaucoma

Isarna Therapeutics announced that the European Medicines Agency (EMA) has granted orphan drug designation for ISTH0036, a locked nucleic acid-modified antisense oligonucleotide, for the prevention of scarring post filtration surgery in glaucoma. With EMA Orphan Drug Designation, Isarna is ... more

All news on pharma

Can a viral co-infection impair immunity against Plasmodium and turn malaria lethal?

It is known that infections with certain viruses can weaken the immune response to another pathogen. A study published in PLOS Pathogens reports provocative findings in mice that infection with the mouse equivalent of Epstein-Barr virus (EBV) can turn infections with certain parasites that ... more

Modifying stem cells shows initial promise in battle against muscular dystrophy

A group of University of Florida Health researchers has found a way to reverse the effects of one type of muscular dystrophy by editing the genome of nervous system stem cells. The findings are an early but important step toward the eventual goal of using stem cell therapy to treat myotonic ... more

Infections can affect your IQ

New research shows that infections can impair your cognitive ability measured on an IQ scale. The study is the largest of its kind to date, and it shows a clear correlation between infection levels and impaired cognition. Anyone can suffer from an infection, for example in their stomach, ur ... more

Phages transducing antibiotic resistance detected in chicken meat

Bacteria resistant to antibiotics are on the rise. There are different explanations for how these resistances are transferred. Researchers from the Vetmeduni Vienna found phages in chicken meat that are able to transfer antimicrobial resistance to bacteria. Phages are viruses that exclusive ... more

UAlberta creates DNA bank to unlock genetic clues about stuttering

Scientists at the University of Alberta's Institute for Stuttering Treatment and Research (ISTAR) want Albertans to give a spit - five millilitres to be precise - to help find the cause and a cure for stuttering.Scientists at the University of Alberta's Institute for Stuttering Treatment an ... more

Novel insights in MET-proto-oncogene might lead to optimizing cancer treatment

The MET-proto-oncogene is involved in the pathogenesis of several tumors and therefore represents an interesting target for future therapies currently tested in dozens of clinical trials. Veronica Finisguerra, Andrea Casazza, Max Mazzone and colleagues from VIB, KU Leuven and UZ Leuven now ... more

'Hydrogels' boost ability of stem cells to restore eyesight and heal brains

Toronto scientists and engineers have made a breakthrough in cell transplantation using a gel-like biomaterial that keeps cells alive and helps them integrate better into tissue. In two early lab trials, this has already shown to partially reverse blindness and help the brain recover from s ... more

Educating the immune system to prevent allergies

With the arrival of spring, millions of Canadians have begun their annual ritual of sneezing and wheezing due to seasonal allergies. A research team at the Montreal Children’s Hospital from the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal is bringing them ... more

Sights set on innovation: New approaches to vision with microchips holds out prospects for the blind

To date, chip-based retinal implants have only permitted a rudimentary restoration of vision. However, modifying the electrical signals emitted by the implants could change that. This is the conclusion of the initial published findings of a project sponsored by the Austrian Science Fund FWF ... more

Engineering bacteria to design vaccines

The EU-funded MycoSynVac project combines gene engineering and biotechnology to design a novel veterinary vaccine chassis based on the bacterium Mycoplasma pneumoniae. By combining their systems biology expertise with cutting-edge synthetic biology methodologies, researchers will engineer ... more

All news on healthcare
News by department
News according to country
Companies in the news
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE